Alpha 2.0
Login Register
» Authors » K H Mayer

K H Mayer

Explore the profile of K H Mayer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 189
Citations 2337
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Public Health
Top 10 Co-Authors
G R Seage 3rd
C C CARPENTER
H M Crane
T P Flanigan
J Eckmayr
N Kumarasamy
R M Nance
S Solomon
W C Mathews
D J Anderson
Published In
Int J STD AIDS
AIDS Care
Am J Med
Clin Infect Dis
J Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
A genome-wide association study of methamphetamine use among people with HIV
Venkataraman A, Jia T, Ruderman S, Haas C, Nance R, Mixson L, et al.
BMC Med Genomics . 2025 Mar; 18(1):46. PMID: 40065283
Background: Amphetamine-like stimulants are the most used psychostimulants in the world; methamphetamine use is the most prevalent in people with HIV. Prolonged methamphetamine use can cause lasting damage to the...
2.
Cannabis use patterns among people with HIV before and after legalization
Hahn A, Ruderman S, Nance R, Delaney J, Whitney B, Eltonsy S, et al.
Drug Alcohol Depend Rep . 2024 Nov; 13:100291. PMID: 39555143
Background: Cannabis use is highly prevalent and detrimental among people with HIV (PWH). Legislative changes in several states altered the legality and accessibility of cannabis. We examined pre-post legislative changes...
3.
Correlates of Intimate Partner Violence, Including Psychological Partner Violence, in a Multisite U.S. Cohort of People in HIV Care
Fredericksen R, Mixson L, Drumright L, Nance R, Delaney J, Ruderman S, et al.
AIDS Behav . 2024 Jul; 28(9):3170-3183. PMID: 39014029
We examined past-year intimate partner violence (IPV), including psychological violence without physical/sexual violence, and health outcomes among people with HIV (PWH) in care in a multi-site U.S. cohort. Between 2016...
4.
Structural vulnerabilities and PrEP awareness among Boston heterosexuals and people who inject drugs at risk for HIV: findings from 2018 to 2019 cycles from the Boston, MA site of the NHBS
Lee J, Batchelder A, Stanton A, Westphal L, Klevens R, Mayer K, et al.
AIDS Care . 2023 Dec; 36(5):641-651. PMID: 38091449
Little is known about biopsychosocial factors relating to pre-exposure prophylaxis (PrEP) awareness among people with either heterosexual or injection drug use HIV risk behaviors. Participants engaged in vaginal/anal sex with...
5.
Influence of Participant Perceptions of Adherence-Related Interactions with Study/Study Team on Drug Levels: HPTN069 Analysis of Self-Reported Adherence Experiences While on Study
Amico K, Mayer K, Landovitz R, Marzinke M, Hendrix C, McCauley M, et al.
AIDS Behav . 2023 Nov; 28(3):1058-1067. PMID: 37947968
Adherence to HIV pre-exposure prophylaxis (PrEP) study drug is critical for safety, tolerability, and efficacy trials, and may be affected by how adherence is communicated by the study staff to...
6.
Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment era
Ma J, Luu B, Ruderman S, Whitney B, Merrill J, Mixson L, et al.
AIDS Care . 2023 Jul; 36(5):618-630. PMID: 37419138
Substance use in people with HIV (PWH) negatively impacts antiretroviral therapy (ART) adherence. However, less is known about this in the current treatment era and the impact of specific substances...
7.
Vaporized nicotine use among patients in HIV care who smoke tobacco: perceived health effects and effectiveness as a smoking cessation tool
Fredericksen R, Fitzsimmons E, Drumright L, Loo S, Dougherty S, Brown S, et al.
AIDS Care . 2023 Mar; 35(11):1741-1748. PMID: 36912767
Evidence suggests adverse health effects from vaporized nicotine (VN) use, such as electronic "e" cigarettes, and limited efficacy to aid tobacco cessation. People with HIV (PWH) smoke tobacco at higher...
8.
Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US
Bender Ignacio R, Shapiro A, Nance R, Whitney B, Delaney J, Bamford L, et al.
medRxiv . 2021 Dec; PMID: 34909782
Objectives: To define the incidence of clinically-detected COVID-19 in people with HIV (PWH) in the US and evaluate how racial and ethnic disparities, comorbidities, and HIV-related factors contribute to risk...
9.
Correlates of psychological intimate partner violence with HIV care outcomes on patients in HIV care
Fredericksen R, Nance R, Whitney B, Harding B, Fitzsimmons E, Del Rio C, et al.
BMC Public Health . 2021 Oct; 21(1):1824. PMID: 34627181
Background: Among people living with HIV (PLWH), physical intimate partner violence (IPV) is associated with poor virologic, psychiatric, and behavioral outcomes. We examined non-physical, psychological intimate partner violence (psy-IPV) and...
10.
Impact and correlates of sub-optimal social support among patients in HIV care
Fredericksen R, Gibbons L, Fitzsimmons E, Nance R, Schafer K, Batey D, et al.
AIDS Care . 2021 Jan; 33(9):1178-1188. PMID: 33443445
Social support (SS) predicts health outcomes among patients living with HIV. We administered a brief, validated measure of SS, the Multifactoral Assessment of Perceived Social Support, within a patient-reported outcomes...